Navigation Links
Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
Date:6/16/2008

ted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com.

Forward Looking Statements

Certain statements in this press release are forward-looking. These forward-looking statements include references to the demand for our Trofile Assay, the potential use of our Trofile Assay for patient selection for Selzentry , or other CCR5 inhibitors, the size and timing of clinical trials utilizing our products, the outlook for Selzentry and our Trofile Assay, expected protection provided by patents and possible regulation of Trofile and our other products by the FDA. These forward-looking statements are subject to risks and uncertainties and other factors, which may cause actual results to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that physicians may not use a molecular diagnostic for patient selection for Selzentry or other HIV drugs; risks related to the implementation of the collaboration with Pfizer; risks and uncertainties relating to the performance of our products; the growth in revenues; the size, timing and success or failure of any clinical trials for CCR5 inhibitors, entry inhibitors or integrase inhibitors; the risk that our Trofile Assay may not be utilized for patient use with Selzentry and other CCR5 inhibitors; our ability to successfully conduct clinical studies and the results obtained from those studies; whether larger confirmatory clinical studies will confirm the results of initial studies; our ability to establish reliable, high-volume operations at commercially reasonable costs; expected reliance on a few customers for the majority of our revenues; the annual renewal of certain customer agreements; actual market acceptance of our products and adoption of our technolo
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
2. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
3. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
4. New Dual Cold Probe From Varian, Inc. Increases Sensitivity and Reduces Analysis Times for 13C NMR Experiments
5. Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
6. Study Reaffirms Superiority of Trofile(TM) Assay
7. New York Medicaid Program Establishes Coverage for Trofile(TM)
8. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
9. ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles
10. Assay Designs(TM) Announces Additions to the Leadership Team
11. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that the ... PVM technology , is now available. The new ... continuously captures high-resolution images under a wide range ... a report pairing the most relevant images to ... compelling blend of high resolution images and trend ...
(Date:12/15/2014)... Dec. 15, 2014  GlassesOff Inc. (OTCBB: GLSO) announced ... as an independent director of the Company,s Board of ... and served as its CEO until its acquisition by ... $240 million transaction. Recognized as the inventor of the ... AeroScout provided Wi-Fi -based RFID solutions focused on improving ...
(Date:12/13/2014)... CHARLOTTE, N.C. (PRWEB) December 13, 2014 ... (UNC Charlotte) spin-out company has changed its name to ... more accurate representation of where we are today,” said ... “We’ve extended our platform’s applications beyond breast cancer diagnostics ... is a reflection of that evolution.” , Founded in ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today that it ... Healthcare Conference on Monday, May 19, 2008 at,10:00 a.m. ... Beach Plaza,Hotel in Monte Carlo, Monaco. Steve Worland, Ph.D., ... overview of Anadys and an,update on its two development-stage ...
... Investments,Inc. (AMEX: MGT ), a technology holding ... today reported financial results,for the first quarter ended ... milestones., Tim Paterson-Brown, MGT Chairman and CEO, ... point for our subsidiaries, Medicsight and,Medicexchange. In the ...
... - Adds significant strategic biotech business experience -, ... Corporation,(Nasdaq: VRNM ), a pioneer in the ... today announced the,appointment of John F. Dee to ... Geoffrey Hazlewood, Ph.D., Senior Vice President of,Research, has ...
Cached Biology Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments 4Verenium Appoints John F. Dee to Board of Directors 2Verenium Appoints John F. Dee to Board of Directors 3Verenium Appoints John F. Dee to Board of Directors 4Verenium Appoints John F. Dee to Board of Directors 5
(Date:12/17/2014)... 15, 2014 The Defense Logistics Agency ... to detect and prevent counterfeit microcircuits from entering ... agency started performing an in-house microcircuit anti-counterfeit initiative ... authenticity of purchased microcircuits while increasing their reliability ... measures will be conducted at DLA,s Electronics Product ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Fla. (April 19, 2010) A unique cell type ... (olfactory system) known as olfactory ensheathing cells (OECs), possess ... and have become prime candidates for transplantation to repair ... (CNS). Transplanted OECs, known to retain exceptional plasticity and ...
... new, dissolvable nicotine pellet--which is being sold as a ... candies--could lead to accidental nicotine poisoning in children, according ... Public Health (HSPH), the Northern Ohio Poison Control Center, ... the Food and Drug Administration (FDA). The researchers also ...
... out Nature,s purpose behind an astonishing variety of tiny ocean ... ticket-holder in life,s lottery, awaiting conditions that will allow it ... of the hardest-to-see sea species -- tiny microbes, zooplankton, larvae ... all other life on Earth -- is the focus of ...
Cached Biology News:Cell transplants may benefit children with cerebral palsy 2Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 3Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 4Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 5Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 6Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 7Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 8Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 9Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 10
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Geneticin Selective Antibiotic liquid...
Biology Products: